PTGS2 and neoplasm: Parallel to lipogenic enhancements, the prostanoid arm of the eicosanoid pathway—most prominently the PTGS2 (COX-2)/Prostaglandin E2 (PGE2) axis—plays a central role across tumor types including hepatobiliary cancers.